Company Quick10K Filing
Repro Med Systems
10-Q 2020-06-30 Filed 2020-08-05
10-Q 2020-03-31 Filed 2020-05-06
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-07
S-1 2019-02-01 Public Filing
10-K 2018-12-31 Filed 2019-03-05
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-06
10-Q 2018-03-31 Filed 2018-05-07
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-04
10-K 2017-02-28 Filed 2017-05-05
10-Q 2016-11-30 Filed 2017-01-05
10-Q 2016-08-31 Filed 2016-10-07
10-Q 2016-05-31 Filed 2016-06-30
10-K 2016-02-29 Filed 2016-05-13
10-Q 2015-11-30 Filed 2016-01-08
10-Q 2015-08-31 Filed 2015-10-02
10-Q 2015-05-31 Filed 2015-07-10
10-K 2015-02-28 Filed 2015-05-08
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-15
10-Q 2014-05-31 Filed 2014-07-15
10-K 2014-02-28 Filed 2014-05-29
10-Q 2013-11-30 Filed 2014-01-14
10-Q 2013-08-31 Filed 2013-10-15
10-K 2013-02-28 Filed 2013-05-29
10-Q 2012-11-30 Filed 2013-01-14
10-Q 2012-08-31 Filed 2012-10-15
10-Q 2012-05-31 Filed 2012-07-16
10-K 2012-02-29 Filed 2012-05-29
10-Q 2011-11-30 Filed 2012-01-17
10-Q 2011-08-31 Filed 2011-10-17
10-Q 2011-05-31 Filed 2011-07-15
10-K 2011-02-28 Filed 2011-05-27
10-Q 2010-11-30 Filed 2011-01-14
10-Q 2010-08-31 Filed 2010-10-15
10-Q 2010-05-31 Filed 2010-07-15
10-K 2010-02-28 Filed 2010-06-01
10-Q 2009-11-30 Filed 2010-01-14
8-K 2020-08-04 Earnings, Exhibits
8-K 2020-06-18
8-K 2020-06-18
8-K 2020-05-20
8-K 2020-05-04
8-K 2020-04-22
8-K 2020-03-23
8-K 2019-11-12
8-K 2019-11-05
8-K 2019-10-23
8-K 2019-10-14
8-K 2019-09-30
8-K 2019-08-30
8-K 2019-06-28
8-K 2019-06-24
8-K 2019-05-07
8-K 2019-04-30
8-K 2019-04-23
8-K 2019-02-12
8-K 2019-02-01
8-K 2018-12-20
8-K 2018-12-17
8-K 2018-12-05
8-K 2018-10-24
8-K 2018-10-23
8-K 2018-10-12
8-K 2018-09-25
8-K 2018-09-04
8-K 2018-08-06
8-K 2018-07-25
8-K 2018-05-03
8-K 2018-04-23
8-K 2018-04-09
8-K 2018-02-13
8-K 2018-01-17

Repro Med Systems Financials

REPR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Diverse Development Group (DDG) 161,311 -3,433.4 -24,302% 0 174 0 0 -43 -47 161,311
Gold Reserve (GDRZF) 161,165 -8.9 -15% 78,340 104,144 0 0 -11,575 -11,575 103,488
Blackstar Enterprise Group (BEGI) 156,000 -313.5 -13,158% 4 279 0 0 -498 -498 156,000
Invesco CurrencyShares British Pound Sterling Trust (FXB) 155,714 0% -5.1 -0% 155,390 51 484 0 -73 -73 369
Northwest Indiana Bancorp (NWIN) 153,605 4.5 1% 1,330,469 1,197,481 0 0 9,823 18,042 81,663
Franklin Financial Services (FRAF) 152,315 0.1 1% 1,301,773 1,175,673 0 0 15,524 25,883 2,181
Pacific Green Technologies (PGTK) 151,900 39% -24.6 -8% 81,816 67,234 69,578 27,194 -6,588 -5,685 140,028
Datawatch (DWCH) 151,567 0% -21.0 -15% 61,684 35,167 42,197 0 -9,252 -6,958 146,374
Invesco CurrencyShares Swiss Franc Trust (FXF) 151,298 -11.9 -1% 143,854 141 0 0 -1,825 -627 7,444
Repro Med Systems (REPR) 148,883 64% 210.8 2% 13,717 2,708 21,211 13,620 289 682 143,754
Metaurus Equity Component Trust (XDIV) 147,784 45.7 13% 24,806 357 0 0 3,222 3,222 147,314
Alliance One (AOI) 146,761 15% 12.1 -5% 1,978,868 1,867,233 1,775,380 260,147 -93,296 120,113 1,452,845
First Keystone (FKYS) 146,539 10.8 1% 1,019,994 892,054 0 0 7,696 17,168 185,789
Cytodyn (CYDY) 171,286 -3.5 -269% 20,874 29,788 0 0 -56,187 -48,802 172,474
Northwest Biotherapeutics (NWBO) 145,700 0% -6.4 -266% 10,145 64,680 1,513 0 -26,969 -24,686 157,385
Kentucky Bancshares (KTYB) 142,320 6.7 1% 1,083,015 965,839 0 0 9,664 17,429 117,030
Windtree Therapeutics (WINT) 138,735 0% -5.8 -24% 100,632 47,561 427 0 -24,027 -22,988 134,144
SolarWindow Technologies (WNDW) 158,348 -31.5 -25% 19,230 260 0 0 -4,722 -4,462 140,358
Mohawk Group (MWK) 136,195 41% -7.6 -26% 72,828 53,320 70,971 29,287 -18,942 -16,635 127,073
First Northern Community Bancorp (FNRN) 136,114 0.0 1% 1,287,263 1,157,741 0 0 11,145 16,699 21

Balance Sheet ($'000)2011-08-312011-11-302012-02-292012-05-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,7091,5661,7571,7271,6821,9301,6331,8351,9212,2272,3392,2422,2482,5572,4713,1573,3404,2023,8613,9663,4403,3132,9833,6624,0333,4213,6493,7392,5933,8075,129
Accounts Receivable6098788857371,1881,1159441,0431,2781,7451,6541,6171,7091,6241,4751,4091,7581,3501,3541,3451,6611,5021,9001,4811,8551,8401,5111,4262,6553,2933,547
Inventory1,0901,0621,1671,3171,1701,1501,2631,1079568191,0251,4411,5711,2271,4131,2961,2591,0401,1241,0741,2991,3541,2671,5871,8011,7181,9492,1042,5092,5722,739
PP&E4074954995819122,4788908988552,6668721,1121,1962,0772,1312,1302,1232,1102,1552,1702,1942,2512,3052,3542,3532,4372,5112,5632,5932,3822,430
Assets4,1544,4524,8054,8055,4025,5925,2515,4295,5946,2096,6717,0947,3877,2817,4287,7108,1948,3948,3358,3438,4758,1708,0048,5919,36010,25810,57710,54511,56311,75113,717
Accounts Payable172310200227203110197249206247520432679243397310522308608710911772279363550712592453943530875
Long-Term Debt32110439
Liabilities1,0341,1531,2541,1641,3141,2367808288051,0171,2891,2021,3961,0081,2121,1521,4231,2761,3931,5401,7391,4949791,2551,2411,5661,4371,5842,3932,2462,708
Stockholders' Equity3,1203,2993,5513,6414,0874,3574,4714,6014,7895,1925,3835,8925,9916,2736,2166,5586,7717,1186,9426,8036,7366,6767,0257,3378,1198,6939,1408,9619,1719,50511,009
Income Statement ($'000)2011-08-312011-11-302012-02-292012-05-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,3621,5012,0331,7442,0701,9981,8762,0082,1802,6352,6372,9622,6553,4482,6313,1663,1453,3062,9903,1483,1932,9623,8295,9954,0334,5024,5474,2714,9745,3496,617
Cost of Revenue1,1131,1591,0361,3371,0531,1931,1291,3481,5322,4101,5671,7631,6561,5571,9261,8732,234
Gross Profit1,5182,0072,1091,9691,9371,9552,0641,6142,2973,5852,4662,8272,8922,7143,0483,4764,383
R&D1027413836363843518613115811761543952635773595425151024127102178170
SG&A6566327818821,1138869519649769611,0941,0881,2571,3491,4781,3911,6981,3752,1802,4142,0341,6222,0052,5031,8802,0232,2042,9892,9773,1752,441
Tax79127229829687757841381261081911001738713392-42-53-2777137110150103-72025187
Net Income11818231890562297310916237715820393299-65335168345-233-83-104-115148731403613387-355-8578652
Cash Flow ($'000)2011-08-312011-11-302012-02-292012-05-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating87302103281214284101355266-46172434116931,001-262346-398-17-237-13969127-1,045-439982
Cash Investing-216-34-122-22-72-82-14-49-154-324-167-100-98-7-58-78-121-108-109-7572-1,630-2-971,629-143
Cash Financing-13-77-11-11-43900002730-2400-81-1-119-20-0-19-424483